CO5440227A1 - Composicion antihelmitica e inyectable mejorada de crecimiento - Google Patents

Composicion antihelmitica e inyectable mejorada de crecimiento

Info

Publication number
CO5440227A1
CO5440227A1 CO03080449A CO03080449A CO5440227A1 CO 5440227 A1 CO5440227 A1 CO 5440227A1 CO 03080449 A CO03080449 A CO 03080449A CO 03080449 A CO03080449 A CO 03080449A CO 5440227 A1 CO5440227 A1 CO 5440227A1
Authority
CO
Colombia
Prior art keywords
injectable composition
antihelmitic
improved growth
composition improved
solvent
Prior art date
Application number
CO03080449A
Other languages
English (en)
Inventor
Vincent Beavry
George Bufala
Guy Derrieu
Original Assignee
Virbac Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virbac Sa filed Critical Virbac Sa
Publication of CO5440227A1 publication Critical patent/CO5440227A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Una composición inyectable, que comprende: un solvente líquido, al menos un agente antihelmíntico seleccionado a partir del grupo que consiste en avermectinas, mibelmicinas, y derivados de las mismas, y al menos un mejorador de crecimiento hormonal, en donde el agente antihelmíntico y el mejorador de crecimiento hormonal se disuelven en el solvente, y donde el solvente líquido se encuentra libre de polimeros sólidos o de formación de película. La composición inyectable según la reivindicación 1, donde el solvente líquido se encuentra compuesto de al menos un solvente hidrofílico.
CO03080449A 2002-09-30 2003-09-12 Composicion antihelmitica e inyectable mejorada de crecimiento CO5440227A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/259,596 US6653288B1 (en) 2002-09-30 2002-09-30 Injectable anthelmintic compositions and methods for using same

Publications (1)

Publication Number Publication Date
CO5440227A1 true CO5440227A1 (es) 2004-09-30

Family

ID=29584164

Family Applications (1)

Application Number Title Priority Date Filing Date
CO03080449A CO5440227A1 (es) 2002-09-30 2003-09-12 Composicion antihelmitica e inyectable mejorada de crecimiento

Country Status (9)

Country Link
US (1) US6653288B1 (es)
CN (1) CN1684664A (es)
AU (1) AU2003274415A1 (es)
CO (1) CO5440227A1 (es)
EC (1) ECSP055710A (es)
MX (1) MXPA03008905A (es)
PA (1) PA8584101A1 (es)
WO (1) WO2004028272A2 (es)
ZA (1) ZA200306952B (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA82359C2 (uk) * 2003-04-03 2008-04-10 Schering Plough Ltd Композиція (варіанти) і спосіб лікування мікробних і паразитних інфекцій у великої рогатої худоби і інших тварин
US7666444B2 (en) * 2004-02-02 2010-02-23 Wyeth Antiparasitic composition
TWI375516B (en) * 2004-06-07 2012-11-01 Syngenta Participations Ag Methods of reducing nematode damage
WO2006007630A1 (en) * 2004-07-22 2006-01-26 Jurox Pty Ltd Aqueous insecticidal/parasiticide formulation
US8541413B2 (en) * 2004-10-01 2013-09-24 Ramscor, Inc. Sustained release eye drop formulations
US20080038316A1 (en) * 2004-10-01 2008-02-14 Wong Vernon G Conveniently implantable sustained release drug compositions
AU2005292145C1 (en) * 2004-10-01 2011-07-21 Ramscor, Inc. Conveniently implantable sustained release drug compositions
US9993558B2 (en) 2004-10-01 2018-06-12 Ramscor, Inc. Sustained release eye drop formulations
US8362086B2 (en) * 2005-08-19 2013-01-29 Merial Limited Long acting injectable formulations
CA2633807A1 (en) * 2005-12-23 2007-06-28 Miv Therapeutics Inc. Compositions formulated for solvent-regulated drug release
US8313752B2 (en) * 2009-04-14 2012-11-20 Merial Limited Macrocyclic lactone combination compositions, vaccines and methods for producing same
US20100310726A1 (en) 2009-06-05 2010-12-09 Kraft Foods Global Brands Llc Novel Preparation of an Enteric Release System
US8859003B2 (en) * 2009-06-05 2014-10-14 Intercontinental Great Brands Llc Preparation of an enteric release system
US20100307542A1 (en) * 2009-06-05 2010-12-09 Kraft Foods Global Brands Llc Method of Reducing Surface Oil on Encapsulated Material
US9968564B2 (en) 2009-06-05 2018-05-15 Intercontinental Great Brands Llc Delivery of functional compounds
KR101352867B1 (ko) * 2011-11-07 2014-01-21 주식회사 한동 동물용 복합항생제 조성물
EP2825154A4 (en) * 2012-03-13 2015-11-11 Bayer New Zealand Ltd LONG ACTIVE COMPOSITIONS
KR101458611B1 (ko) * 2012-08-02 2014-11-11 주식회사 한동 동물용 복합항생제 조성물
US8859005B2 (en) 2012-12-03 2014-10-14 Intercontinental Great Brands Llc Enteric delivery of functional ingredients suitable for hot comestible applications
CN105078801B (zh) * 2014-05-12 2019-01-04 南京点元环境科技有限公司 一种绿色健康洗甲水
ES2483599B2 (es) 2014-05-26 2015-03-31 Sipcam Inagra, S.A. Composición Sinérgica Surfactante
CN104984334B (zh) * 2015-06-26 2018-06-26 金宇保灵生物药品有限公司 一种狂犬病弱毒苗-吡喹酮复合剂及其制备方法与应用
CN105746908B (zh) * 2016-02-23 2018-08-28 广州英赛特生物技术有限公司 肉豆蔻酸衍生物在制备动物生长促进剂中的应用
CN107375205B (zh) * 2017-07-31 2019-11-08 佛山市南海东方澳龙制药有限公司 非油性多拉菌素注射液及其制备方法和应用
EP3897618A4 (en) * 2018-12-21 2022-11-16 Elanco US Inc. PARASTITIC FORMULATIONS AND USE THEREOF
CN110585124A (zh) * 2019-09-26 2019-12-20 西安力邦医药科技有限责任公司 一种含有雌三醇或其衍生物的油性注射剂

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3239345A (en) 1965-02-15 1966-03-08 Estrogenic compounds and animal growth promoters
US3950360A (en) * 1972-06-08 1976-04-13 Sankyo Company Limited Antibiotic substances
US4199569A (en) * 1977-10-03 1980-04-22 Merck & Co., Inc. Selective hydrogenation products of C-076 compounds and derivatives thereof
US4778821A (en) 1987-07-15 1988-10-18 International Minerals & Chemical Corp. Method for controlling helmintic parasites
US5332577A (en) 1988-12-27 1994-07-26 Dermamed Transdermal administration to humans and animals
NZ234802A (en) 1989-08-14 1992-11-25 Merck & Co Inc Long acting injectable formulations comprising an avermectin compound and triacetin. treatment for internal and external parasites of animals
US5288496A (en) 1990-05-15 1994-02-22 Stolle Research & Development Corporation Growth promoters for animals
US5733566A (en) 1990-05-15 1998-03-31 Alkermes Controlled Therapeutics Inc. Ii Controlled release of antiparasitic agents in animals
ES2131515T3 (es) 1991-09-30 1999-08-01 Merck & Co Inc Formulados inyectables de accion prolongada que contienen aceite de ricino hidrogenado.
US5686092A (en) 1992-11-24 1997-11-11 Alkermes Controlled Therapeutics Inc. Ii Growth promoters for animals
US5773422A (en) * 1996-01-29 1998-06-30 Komer; Gene Avermectin formulation
US6733767B2 (en) 1998-03-19 2004-05-11 Merck & Co., Inc. Liquid polymeric compositions for controlled release of bioactive substances
US6174540B1 (en) 1998-09-14 2001-01-16 Merck & Co., Inc. Long acting injectable formulations containing hydrogenated caster oil
US6953586B1 (en) 2000-06-08 2005-10-11 Ivy Animal Health, Inc. Growth promoting pharmaceutical implant

Also Published As

Publication number Publication date
ECSP055710A (es) 2005-08-11
WO2004028272A3 (en) 2004-05-21
CN1684664A (zh) 2005-10-19
AU2003274415A1 (en) 2004-04-19
WO2004028272A2 (en) 2004-04-08
MXPA03008905A (es) 2005-10-05
AU2003274415A8 (en) 2004-04-19
ZA200306952B (en) 2005-02-23
US6653288B1 (en) 2003-11-25
PA8584101A1 (es) 2004-05-21

Similar Documents

Publication Publication Date Title
CO5440227A1 (es) Composicion antihelmitica e inyectable mejorada de crecimiento
BRPI0409185A (pt) formulações veterinárias anti-helmìnticas tópicas
CL2003002277A1 (es) Composicion farmaceutica inyectable, de deposito de liberacion prolongada, que comprende un agente beneficioso disuelto o disperso en un gel constituido por un polimero bioerosionable y biocompatible; y un solvente.
UY26391A1 (es) Inhibidores sglt2 de glucosidos de c-arilo y metodo
PE20110236A1 (es) Proteccion y mejoramiento de celulas, tejidos y organos que responden a la eritropoyetina
ES2178268T3 (es) Formulaciones de liberacion controlada.
AR030245A1 (es) Composiciones de gel que contienen metronidazol
ES2570856T3 (es) Composiciones oftálmicas que contienen una combinación sinérgica de dos polímeros
PA8509001A1 (es) Forma de dosificacion de farmacos accionada por un hidrogel
DE60319355D1 (de) Kaubare weichkapsel
AR009127A1 (es) Procedimiento de preparacion de nanoparticulas de metilideno malona, particulas que contienen eventualmente una o mas moleculas biologicamente activas y composiciones farmaceuticas que las contienen
BRPI0600194A (pt) composições farmacêuticas contendo docetaxel e um inibidor de degradação e processo de obtenção das mesmas
ATE485049T1 (de) Physiologisch aktive zusammensetzung gegen diabetes
PE20040499A1 (es) Nuevas formulaciones de liberacion prolongada inyectables
AR109263A2 (es) Composición que comprende moxidectina
ECSP055566A (es) Formulaciones de depósito de corta duración
DE60017361D1 (de) Direktverpressbare matrix zur kontrollierten abgabe von einmaltäglichen dosen von clarithromycin
PE20020833A1 (es) Composiciones quimioterapicas de paclitaxel en microemulsion con mayor biodisponisibilidad oral
EA200701542A1 (ru) Антигельминтная композиция
AR024959A1 (es) Una composicion farmaceutica liquida basada en paracetamol
EE05124B1 (et) Toimeainena dotsetakseeli v?i selle hdraati sisaldava kompositsiooni kasutamine
AR031056A1 (es) Composicion cosmetica que proporciona buenas propiedades de estabilidad y que incluye un copolimero de unidad acido
DE602004011754D1 (de) Polymerische gele mit kontrollierter wirkstofffreisetzung
ATE444739T1 (de) Polymerzusammensetzung sowie diese enthaltende darreichungsformen
PA8618401A1 (es) Prevencion y tratamiento de enfermedades cardiacas hipertensivas mediante el uso de los estrogenos selectivos 8beta-vinil-estra-1,3,5(10)-trien-3,17beta-diol y 17beta-fluor-9alfa-vinil-estra-1.3,5(10)-trien-3,16alfa-diol

Legal Events

Date Code Title Description
FC Application refused